Center for Diabetes & Metabolic Diseases Pilot & Feasibility Grant: Category 4
Indiana Clinical and Translational Sciences Institute (CTSI)
Funding Amount
Up to US $50,000
Deadline
Deadline not published
Grant Type
Foundation
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- These funding opportunities invite applications from investigators at Indiana University School of Medicine and other Indiana University campuses (IU Bloomington, IU Muncie, etc.), Purdue University, University of Notre Dame and the Indiana Biomedical Research Institute (IBRI).
- Note that established non-diabetes and diabetes-related investigators with previous and/or ongoing substantial NIH-supported independent research awards can submit applications pursuing high impact/high risk projects or projects that are a significant departure from their usual work.
Other requirements
- All eligible investigators must have faculty appointments, be independent investigators and have the education, skills, knowledge, and resources necessary to carry out the proposed research.
- Work supported by these funds is expected to lead to submissions of major extramural grants (R01/equivalent NIH, major foundation awards, DOD, etc.)National and international collaborations are allowed.
Not eligible / not funded
- Not eligible: Postdoctoral fellows or their equivalent are not eligible.
- Not eligible: Travel to conferences or seminars are not an allowable expense.
- Not eligible: Budget requests may not include indirect costs, F&A, or PI salaries.
Overview
The Center for Diabetes & Metabolic Diseases offers a Pilot & Feasibility Grant to support innovative research in diabetes and metabolic diseases. This grant invites applications for new research techniques applicable in CDMD Core facilities with awards of up to $50,000 for one year. Eligible applicants include independent investigators from specific Indiana institutions, focusing on high-risk projects that may lead to major extramural grant submissions.
Center for Diabetes & Metabolic Diseases Pilot & Feasibility Grant
A primary research-related activity of the Center for Diabetes and Metabolic Diseases (CDMD)’s Pilot and Feasibility (P&F) program is to foster the development of new diabetes-related investigators and provide seed-support for innovative, high-risk projects.
The CDMD P&F program has three different grant mechanisms:
Parent P&F Grants: This mechanism invites applications directed towards basic biomedical, clinical, and/or translational research questions on cellular and molecular metabolism related to diabetes/obesity/metabolic syndrome, clinical and outcomes research in diabetes and obesity, complications of diabetes and obesity, islet function and survival, and nutrition and physiology of diabetes and obesity.
Alzheimer’s-Focused P&F Grants: This mechanism invites applications focused on diabetes and metabolic disease aspects of Alzheimer’s disease and its related dementias (AD/ADRD)–frontotemporal dementia, Lewy body dementia, vascular cognitive impairment with dementia, and multiple etiology dementias.
Physician-Scientist P&F Grants: This mechanism invites applications from exceptional emerging physician-scientists holding an MD (or equivalent) or MD/PhD with a patient-oriented diabetes and/or obesity-related clinical research project, who are early in their clinical research careers and show great promise to develop into future independent investigators.
Investigators developing new research techniques/technologies that could be used in a CDMD Core facility
Awards are up to $50,000 for one year
Travel budget requested must be limited to those expenses necessary to carry out the specific aims of the proposed project.Graduate student stipends (only) are an allowable expense.
Publication fees are deemed an allowable expense.
Eligibility
All eligible investigators must have faculty appointments, be independent investigators and have the education, skills, knowledge, and resources necessary to carry out the proposed research. These funding opportunities invite applications from investigators at Indiana University School of Medicine and other Indiana University campuses (IU Bloomington, IU Muncie, etc.), Purdue University, University of Notre Dame and the Indiana Biomedical Research Institute (IBRI).Work supported by these funds is expected to lead to submissions of major extramural grants (R01/equivalent NIH, major foundation awards, DOD, etc.)National and international collaborations are allowed.Note that established non-diabetes and diabetes-related investigators with previous and/or ongoing substantial NIH-supported independent research awards can submit applications pursuing high impact/high risk projects or projects that are a significant departure from their usual work.
Ineligibility
Postdoctoral fellows or their equivalent are not eligible.Travel to conferences or seminars are not an allowable expense.Budget requests may not include indirect costs, F&A, or PI salaries.
Focus Areas & Funding Uses
Fields of Work
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Stark Neurosciences- Pre-Clinical Neuroimaging Pilot Grant: Category 1
Indiana Clinical and Translational Sciences Institute (CTSI)
Amount
Up to US $10,000
Deadline
Deadline not published
Parkinson's Disease Therapeutics Pipeline Grant Program
The Michael J Fox Foundation for Parkinson's Research
Amount
US $250,000 - US $2,000,000
Deadline
October 30, 2026
Listed date — confirm with the funder
GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)
National Institutes of Health
Amount
$2,000,000 total
Deadline
October 30, 2026
GREGoRi Technology Integration Center (U01, Clinical Trials Optional)
National Institutes of Health
Amount
$3,000,000 total
Deadline
October 30, 2026
Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed)
National Institutes of Health
Amount
$50,000 - $100,000
Deadline
November 10, 2026
Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$6,300,000 total
Deadline
November 9, 2026
Ready to apply for Center for Diabetes & Metabolic Diseases Pilot & Feasibility Grant: Category 4?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Center for Diabetes & Metabolic Diseases Pilot & Feasibility Grant: Category 4. Now let's win it.